AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression
Joseph Gera(University of California, Los Angeles), Alan Lichtenstein(University of California, Los Angeles)
Cited by 329
Related Papers
Heterogeneous Nuclear Ribonucleoprotein A1 Regulates Cyclin D1 and c-myc Internal Ribosome Entry Site Function through Akt Signaling
|Journal of Biological Chemistry|2008|125
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
|International Journal of Molecular Sciences|2020|33